Cortexyme announces third quarter 2020 financial results and provides business update

South san francisco, calif.--(business wire)--cortexyme, inc. (nasdaq: crtx), a clinical-stage biopharmaceutical company pioneering potential therapeutics for alzheimer's and other degenerative diseases, today announced financial results for the third quarter 2020 and provided an update on its business. “we are pleased with the strong participation in the gain trial and deeply appreciate the support and dedication of patients and the medical community as we approach the interim analysis before
QNCX Ratings Summary
QNCX Quant Ranking